MAP3K3 and neoplasm: This suggests that the gene signatures regulated by MAP3K3 differ in vitro and in vivo due to the altered tumor microenvironment the overexpression of MAP3K3 correlating with a favorable patient outcome reflects an active immune response in which related anti-tumor genes kill more tumor cells and hence improve patient survival.